These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3889532)

  • 1. The role of prostacyclin in patients with portal hypertension.
    Hashizume M; Inokuchi K; Tanaka K
    Liver; 1985 Apr; 5(2):89-93. PubMed ID: 3889532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
    Yin J; Leng X; Zhu J
    Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic prostacyclin in cirrhotic patients. Relationship with portal hypertension and changes after intestinal decontamination.
    Guarner C; Soriano G; Such J; Teixidó M; Ramis I; Bulbena O; Roselló J; Guarner F; Gelpi E; Balanzó J
    Gastroenterology; 1992 Jan; 102(1):303-9. PubMed ID: 1727763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of portosystemic shunting on PGI2 and glucagon levels in humans.
    Sitzmann JV; Campbell KA; Wu Y; Cameron JL
    Ann Surg; 1993 Mar; 217(3):248-52. PubMed ID: 8452403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.
    Maruyama H; Kobayashi K; Kiyono S; Yokosuka O
    Int J Med Sci; 2017; 14(3):240-245. PubMed ID: 28367084
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis.
    Sarin SK; Sethi KK; Nanda R
    Gut; 1987 Mar; 28(3):260-6. PubMed ID: 3570030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal hemodynamics in cirrhotics with portal hypertension using color Doppler velocity profile.
    Huang J; Yin X; Lu M; Chen J; Liang L
    Chin Med J (Engl); 1999 Jul; 112(7):627-31. PubMed ID: 11601258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin in the circulation of patients with vascular disorders undergoing surgery.
    Ritter JM; Hamilton G; Barrow SE; Heavey DJ; Hickling NE; Taylor KM; Hobbs KE; Dollery CT
    Clin Sci (Lond); 1986 Dec; 71(6):743-7. PubMed ID: 3539459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of portal hypertension.
    MacMathuna PM
    Drugs; 1992; 44 Suppl 2():1-13; discussion 70-2. PubMed ID: 1385066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.
    Iwao T; Toyonaga A; Oho K; Shigemori H; Sakai T; Tayama C; Masumoto H; Sato M; Tanikawa K
    J Hepatol; 1996 Oct; 25(4):491-7. PubMed ID: 8912148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porto-systemic collaterals in cirrhosis of the liver. Selective percutaneous transhepatic catheterization of the portal venous system in portal hypertension.
    Hoevels J; Lunderquist A; Tylén U; Simert G
    Acta Radiol Diagn (Stockh); 1979; 20(6):865-77. PubMed ID: 546069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for role of prostacyclin as a systemic hormone in portal hypertension.
    Sitzmann JV; Li SS; Adkinson NF
    Surgery; 1991 Feb; 109(2):149-53. PubMed ID: 1992548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal pressure and collaterals in cirrhotic patients.
    Kallio H
    Ann Chir Gynaecol; 1984; 73(6):308-12. PubMed ID: 6335642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between prostacyclin activity and pressure in the portal vein.
    Hamilton G; Phing RC; Hutton RA; Dandona P; Hobbs KE
    Hepatology; 1982; 2(2):236-42. PubMed ID: 7040200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum aminoterminal procollagen type III propeptide as an index of portal hypertension and esophageal varices in chronic liver diseases.
    Gressner AM; Tittor W; Kropf J
    Clin Chim Acta; 1988 May; 174(2):163-70. PubMed ID: 3383441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
    Gioia S; Nardelli S; Pasquale C; Pentassuglio I; Nicoletti V; Aprile F; Merli M; Riggio O
    Dig Liver Dis; 2018 Aug; 50(8):839-844. PubMed ID: 29429910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy.
    Ohta M; Kishihara F; Hashizume M; Kawanaka H; Tomikawa M; Higashi H; Tanoue K; Sugimachi K
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jul; 53(1):41-5. PubMed ID: 7675821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension.
    Procopet B; Cristea VM; Robic MA; Grigorescu M; Agachi PS; Metivier S; Peron JM; Selves J; Stefanescu H; Berzigotti A; Vinel JP; Bureau C
    Dig Liver Dis; 2015 May; 47(5):411-6. PubMed ID: 25732434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ; Böker KH; Horn W; Günzler V; Manns MP
    Hepatogastroenterology; 1997; 44(16):1200-5. PubMed ID: 9261625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.